LifeMD logo

LifeMD(NASDAQ) LFMDP

Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2021)+56%
5 Year+56%
1 Year-2%
1 Month-6%
$22.25
-2.67%
-0.61Today
After hours$21.46-$0.79 (-3.55%)
LifeMD last closing stock price
MetricPriceDate
Last closeUSD 21.302026-10-23
LifeMD stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-3.98%USD 22.182026-10-16
1 month-5.99%USD 22.662026-09-23
3 month-7.32%USD 22.982026-07-24
Year to date+6.36%USD 20.032025-12-31
1 year-2.06%USD 21.752025-10-23
3 year+57.33%USD 13.542023-10-24
5 year+56.14%USD 13.642021-10-22
Since inception+56.14%USD 13.642021-10-05

LifeMD Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$204.48M

Net Income (TTM)

-$21.26M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$2.22

Beta (Volatility)

0.15 (Low)

Price

$22.25

Volume

2,395

Open

$21.63

Previous Close

$21.60

Daily Range

$21.04 - $21.63

52-Week Range

$18.50 - $24.20

Estimated Earnings Date

Nov 9, 2026

LFMDP News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About LifeMD

LifeMD, Inc. operates as a direct-to-patient telehealth enterprise, connecting individuals with healthcare professionals across the United States. The company offers a diverse range of medical services, including personalized concierge care and specialized treatments in areas such as men's sexual health and dermatology.

Products and Services
  • ShapiroMD provides comprehensive hair loss solutions through virtual consultations and FDA-approved treatments
  • RexMD offers virtual medical treatment for various men's health needs
  • LifeMD Primary Care delivers personalized virtual primary and urgent care services
Growth Outlook
  • Revenue for Q2 2026 reached $47.3 million, showing strong demand for telehealth services
  • Year-over-year revenue growth indicates increasing market penetration and consumer adoption
  • Expansion into new telehealth specialties is expected to drive future revenue growth
Financial Highlights
  • Trailing twelve months (TTM) revenue stands at $188.5 million, reflecting robust business performance
  • Gross profit margin improved to 88.8% in Q2 2026, indicating effective cost management
  • Cash and cash equivalents totaled $25.1 million as of June 30, 2026, providing liquidity for operations
LifeMD, Inc. is positioned in the rapidly growing telehealth sector, which has gained significant traction due to increased consumer demand for accessible healthcare solutions. The company's diverse portfolio of telehealth brands allows it to cater to various medical needs, enhancing its market presence. Recent financial performance highlights a strong revenue trajectory, with substantial gross profit margins, indicating effective operational efficiency. The liquidity position also supports ongoing investments in growth initiatives, making LifeMD an intriguing option for potential investors interested in the healthcare technology space.
AI Generated • Oct 15, 2026

Industry

Health Care Technology

Headquarters

New York City, NY 10001, US

LFMDP Financials

Key Financial Metrics (TTM)

Gross Margin

85.91%

Operating Margin

-9.35%

Net Income Margin

-10.40%

Return on Equity

-179.12%

Return on Capital

-26.02%

Return on Assets

-35.50%

Earnings Yield

N/A

Dividend Yield

10.42%

Payout Ratio

-14.61%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

0

Volume

2.40K

Avg. Volume

1.67K

Financials (TTM)

Gross Profit

$175.67M

Operating Income

-$19.13M

EBITDA

-$11.18M

Operating Cash Flow

-$9.91M

Capital Expenditure

$2.72M

Free Cash Flow

-$7.19M

Cash & ST Invst.

$25.14M

Total Debt

$6.02M

LifeMD Performance Analysis

LifeMD sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-3.3%
Q42025-12-31-22.1%
Q12026-03-317.0%
Q22026-06-30-5.7%
LifeMD sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-54.7%
Q42025-12-3151.1%
Q12026-03-31-311.5%
Q22026-06-3020.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$47.28M

-24.0%

Gross Profit

$42.00M

-23.3%

Gross Margin

88.82%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

389

N/A

Net Income

-$7.08M

-241.4%

EBITDA

-$5.05M

-674.3%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$25.14M

-30.6%

Total Debt

$6.02M

-72.7%

Accounts Receivable

$11.50M

+56.9%

Inventory

$2.96M

-9.1%

Long Term Debt

$5.32M

-44.3%

Short Term Debt

$699.51K

-94.4%

Return on Assets

-35.50%

N/A

Return on Invested Capital

-1.44%

N/A

Free Cash Flow

-$10.51M

-191.4%

Operating Cash Flow

-$6.93M

-180.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
DNTHDianthus Therapeutics, Inc.
$79.33+3.32%
ELVNEnliven Therapeutics, Inc.
$41.49-0.07%
PLSEPulse Biosciences, Inc.
$52.66-0.68%
OPKOPKO Health, Inc.
$1.63+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NUNu Holdings
$12.59-16.95%
EWZiShares - iShares Msci Brazil ETF
$34.15-19.82%
ITUBItaú Unibanco
$7.70-20.37%
XPXP
$15.71-48.36%

Questions About LFMDP

What is the current price of LifeMD?

LifeMD is trading at $21.60 per share.

What is the 52-week range for LifeMD?

Over the past 52 weeks, LifeMD has traded between $18.50 and $24.20.

How much debt does LifeMD have?

LifeMD total debt is unavailable.

How much cash does LifeMD have on hand?

LifeMD does not have cash on hand data available.

What is LifeMD’s dividend yield?

LifeMD currently has a dividend yield of 10.42%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.